The glutamate homeostasis hypothesis of addiction
The DOI matches its Crossref record; 150 of the 151 references it cites were found in a registry or an index.
Abstract
Addiction is associated with neuroplasticity in the corticostriatal brain circuitry that is important for guiding adaptive behaviour. The hierarchy of corticostriatal information processing that normally permits the prefrontal cortex to regulate reinforcement-seeking behaviours is impaired by chronic drug use. A failure of the prefrontal cortex to control drug-seeking behaviours can be linked to an enduring imbalance between synaptic and non-synaptic glutamate, termed glutamate homeostasis. The imbalance in glutamate homeostasis engenders changes in neuroplasticity that impair communication between the prefrontal cortex and the nucleus accumbens. Some of these pathological changes are amenable to new glutamate- and neuroplasticity-based pharmacotherapies for treating addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key synaptic changes involve glutamate-modulated N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in glutamatergic projections from the prefrontal cortex and amygdala to the ventral tegmental area and nucleus accumbens (table 2, circuit 4).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [32]
In the citing paper
“Associations with SmkInit highlighted structures and functions related to long-term potentiation and reward-related learning and memory, systems that affect reward processing and addiction28,34,35.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“DLG4 affects NMDA receptors and potassium channel clusters, and plays a central role in glutamatergic models of reward-related learning35.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“which affects addictive behavior in mice35,36 and regulates glutamate metabotropic receptor 1 (GRM1).”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [35]
In the citing paper
“According to the results of animal studies, glutamatergic projections from prefrontal cortex and from amygdala into VTA/SN and NAc mediate these conditioned responses (Kalivas 2009).”
From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Kalivas 2009
Citations
Cites
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527 · cited 1×
“The anatomical and functional hierarchy of projections from the cortex to the basal ganglia is well characterize”
BackgroundThe neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
Everitt, B. J., & Robbins, T. W. (2005) · Nature Neuroscience · doi:10.1038/nn1579 · Cited by 3,785 · cited 1×
“A corticostriatal circuitry of addiction A common perspective on addiction is that, with repeated drug use, drug-seeking behaviours become more habitual and less amenable to regulation by environmental contingencies, a viewpoint developed in recent review”
BackgroundDopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“Accordingly, the release of dopamine by addictive drugs is important for progressively shaping drug use into drug-seeking behaviours that are difficult to contro”
BackgroundGoldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647 · cited 1×
“Changes in the level or activity state of proteins after chronic drug administration have been intensively researched; for excellent reviews describing drug effects on transcriptional regulators and cell signalling proteins, see Ref”
BackgroundThe role of the basal ganglia in habit formation
Yin, H. H., & Knowlton, B. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1919 · Cited by 2,402 · cited 1×
“Corticostriatal projections are responsible not only for generating learnt, well-established behaviours such as in drug taking, but also for changing behaviours in response to a variable environment, and thereby generating new adaptive behaviour”
Background
Cited by
Items 601–700 of 1,000
Caffino, L., Giannotti, G., Messa, G., Mottarlini, F., & Fumagalli, F. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1433328 · Cited by 26
Role of prefrontal cortex in the extinction of drug memories
Zhang, W., Cao, K.-X., Ding, Z., Yang, J., Pan, B., & Xue, Y.-X. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5069-3 · Cited by 24
Bertrand, S. J., Hu, C. T., Aksenova, M. V., Mactutus, C. F., & Booze, R. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00894 · Cited by 27
“Conversely, chronic cocaine exposure in rats increased the expression of F-actin (Kalivas, 2009) and increases dendritic spine density (Martin et al.”
BackgroundHeterodimer of A2A and oxytocin receptors regulating glutamate release in adult striatal astrocytes
Amato, S., Averna, M., Guidolin, D., Pedrazzi, M., Pelassa, S., Capraro, M., Passalacqua, M., Bozzo, M., Gatta, E., Anderlini, D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042326 · Cited by 23
“According to the glutamate homeostasis hypothesis of substance use disorder, alterations of striatal astrocyte function may have implications in addiction: imbalance in glial regulation of glutamatergic transmission at prefrontal-to-accumbens synapses in chronic drug use may lead to drug seeking and relapse [94] and r…”
BackgroundCherneva, D. I., Kehayova, G. K., Dimitrova, S., & Dragomanova, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090710 · Cited by 25
“Additional preclinical investigations suggest that NAC may diminish drug-seeking behavior in rodent models by influencing xCT antiporter and glutamate transporter 1 (GLT-1) in NAc and prefrontal cortex [22,75,76].”
The neural circuits and signalling pathways of opioid use disorder
Mathis, V., Ehrlich, A. T., & Darcq, E. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00982-7 · Cited by 25
“Here, we discuss some of the cellular and molecular effects of opioids that have been hypothesized to contribute to OUD, although further research is required to demonstrate their roles in the disorder.”
Thalamic glutamate decreases with cigarette smoking
O’Neill, J., Tobias, M. C., Hudkins, M. R., Oh, E. Y., Hellemann, G. S., Nurmi, E. L., & London, E. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3441-5 · Cited by 25
“Our finding of diminished thalamic Glu with increased smoking is consistent with the notable drop in extracellular Glu measured or postulated in other brain regions (Baker et al. 2003; Madayag et al. 2007; McFarland et al. 2003) in rodents self-administering cocaine or nicotine, due to downregulation of xCT and EAAT2…”
BackgroundResultInfluentialAmantadine in the Treatment of Pathological Gambling: A Case Report
Pettorruso, M., Martinotti, G., Nicola, M. D., ONOFRJ, M. C., Giannantonio, M. D., Conte, G., & Janiri, L. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00102 · Cited by 24
“…modulates Glu homeostasis, we hypothesize that its therapeutic action is linked to the restoration of prefrontal projections to the ventral striatum (nucleus accumbens), thus reversing neuroplasticity-based pathological changes putatively determined by addictive behaviors (Kalivas, 2009).”
InfluentialHughes, B. W., Huebschman, J. L., Tsvetkov, E., Siemsen, B. M., Snyder, K. K., Akiki, R. M., Wood, D. J., Penrod, R. D., Scofield, M. D., Berto, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50099-1 · Cited by 23
Levran, O., Peles, E., Randesi, M., da Rosa, J. C., Ott, J., Rotrosen, J., Adelson, M., & Kreek, M. J. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.003 · Cited by 25
“…provided evidence for an essential role for the glutamatergic and the GABAergic systems in drug addiction and indicated an effect of genetic background and impairments in synaptic plasticity (Xi and Stein, 2000; Kalivas, 2009; Miguens et al., 2013; Schlussman et al., 2013; Gipson et al., 2014).”
BackgroundXie, P., Kranzler, H. R., Krystal, J. H., Farrer, L. A., Zhao, H., & Gelernter, J. E. (2013) · Addiction Biology · doi:10.1111/adb.12072 · Cited by 25
“Similarly, neuroadaptations in NMDA, AMPA and several metabotropic glutamate receptors contribute to features of tolerance, sensitization and withdrawal from ethanol, opiates, nicotine and cocaine (Siggins et al. 2003; Krystal et al. 2003b; Liechti & Markou 2008; Kalivas 2009; Chambers et al. 2001).”
BackgroundPsychological and Neurobiological Precursors of Alcohol Use Disorders in High-Risk Youth
Hill, S. Y., & O’Brien, J. W. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0051-1 · Cited by 23
Claussen, C. M., Chong, S. L., & Dafny, N. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.024 · Cited by 24
“The VTA interacts with the pre-frontal cortex (PFC) glutamatergic transmission facilitating the rewarding actions of psychostimulants [7,8].”
BackgroundKurosawa, R., Taoka, N., Shinohara, F., Minami, M., & Kaneda, K. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12296 · Cited by 25
Castilla‐Ortega, E., Pavón, F. J., Sánchez‐Marín, L., Estivill‐Torrús, G., Pedraza, C., Blanco, E., Suárez, J., Santín, L. J., de Fonseca, F. R., & Serrano, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.010 · Cited by 24
“…these findings will be addressed in future experiments, they support the idea that the PFC is a key brain region for ethanol actions and ethanol-induced alterations in PFC structure and function is involved in alcohol addiction (Abernathy et al., 2010; Weitlauf and Woodward, 2008; Kalivas, 2009).”
Abad, S., Camarasa, J., Pubill, D., Camins, A., & Escubedo, E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9618-z · Cited by 27
“Drugs of abuse, such as psychostimulants, usurp the normal basic reward function, essentially hijackingmolecular and cellular processes, such as those involved in addiction, leading to persistent adaptive behavioral responses [64].”
BackgroundNeural correlates of 12-h abstinence-induced craving in young adult smokers: a resting-state study
Li, Y., Yuan, K., Bi, Y., Guan, Y., Cheng, J., Zhang, Y., Shi, S., Lu, X., Yu, D., & Tian, J. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9544-3 · Cited by 23
“…been demonstrated that chronic drug use causes an imbalance between the regions that mediate reward processing (e.g., striatal network) and regions that mediate regulatory behavior (e.g., frontal cortex) (Volkow et al. 2013), which is mainly associated with fronto-striatal circuits (Kalivas 2009).”
BackgroundXie, X., Liu, H., Zhang, J., Chen, W., Zhuang, D., Duan, S., & Zhou, W. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.08.025 · Cited by 23
Hicks, C., Gregg, R. A., Nayak, S. U., Cannella, L. A., Schena, G. J., Tallarida, C. S., Reitz, A. B., Smith, G. R., & Rawls, S. M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4568-y · Cited by 25
“…is also influenced by the group II metabotropic glutamate 2 and 3 (mGluR2/3) receptors, which act to inhibit excessive synaptic GLU release evoked by drug cues or stress that is thought to trigger relapse behavior (Baptista et al. 2004; Kalivas and Volkow 2005; Kalivas 2009; Liechti et al .”
BackgroundResultInfluentialA Role for Sigma Receptors in Stimulant Self-Administration and Addiction
Katz, J. L., Hiranita, T., Hong, W. C., Job, M. O., & McCurdy, C. R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_94 · Cited by 23
Ibrahim, K. S., Abd‐Elrahman, K. S., Mestikawy, S. E., & Ferguson, S. S. G. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.000089 · Cited by 23
“Follow-up studies demonstrated that mGluR5 suppression reduced cocaine and nicotine self-administration (Kalivas, 2009; Li et al. , 2018).”
BackgroundAstrocyte modulation of extinction impairments in ethanol-dependent female mice
Giacometti, L. L., Chandran, K., Figueroa, L. A., & Barker, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108272 · Cited by 23
“Multiple glutamatergic and dopaminergic projections to the nucleus accumbens (NAc) have been implicated in various aspects of reward-seeking behavior, including contingency learning, consummatory behavior, and extinction (Kalivas, 2009).”
BackgroundmGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving
Murray, C. H., Christian, D., Milovanovic, M., Loweth, J. A., Hwang, E.-K., Caccamise, A. J., Funke, J. R., & Wolf, M. E. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108452 · Cited by 25
“This latter finding may be related to work showing that reduced extracellular glutamate levels promote relapse-like behavior by reducing activation of presynaptic glutamate autoreceptors that normally oppose such behavior (Kalivas, 2009).”
BackgroundHassanlou, A. A., Jamali, S., RayatSanati, K., Mousavi, Z., & Haghparast, A. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.04.007 · Cited by 23
Odeón, M. M., Andreu, M., Yamauchi, L., Grosman, M., & Acosta, G. B. (2015) · Stress · doi:10.3109/10253890.2015.1041909 · Cited by 25
“The FC is directly linked to reward systems (dopaminergic projections of the ventral tegmental area (VTA) (Kalivas, 2009).”
BackgroundNussbaum, D. S., Honarmand, K., Govoni, R., Kalahani-Bargis, M., Bass, S. N., Ni, X., LaForge, K., Burden, A. M., Romero, K., Basarke, S., et al. (2010) · Journal of Gambling Studies · doi:10.1007/s10899-010-9219-8 · Cited by 23
“Additional details of this mechanism are provided in Kalivas (2009).”
BackgroundFerrario, C. R., Goussakov, I. V., Stutzmann, G. E., & Wolf, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040898 · Cited by 23
“Excitatory transmission onto MSN of the NAc is critical for cocaine seeking behavior in several rodent models of cocaine addiction”
O’Donovan, B., Neugornet, A., Neogi, R., Xia, M., & Ortinski, P. I. (2021) · Addiction Biology · doi:10.1111/adb.13042 · Cited by 25
“However, available evidence indicates that extrasynaptic glutamate is decreased in the NAc following chronic cocaine.(38,75) Although glutamate release events associated with SICs may not substantially contribute to ambient extracellular glutamate levels, our finding that the”
Nedelescu, H., Wagner, G. E., Ness, G. L. D., Carroll, A. M., Kerr, T. M., Wang, J., Zhang, S., Chang, S. E., Than, A., Emerson, N. E., et al. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.06.014 · Cited by 23
“NAc core (NAcc), and NAc shell (NAcs) (13,15).”
Prisciandaro, J. J., Mellick, W. H., Squeglia, L. M., Hix, S., Arnold, L., & Tolliver, B. K. (2021) · Addiction Biology · doi:10.1111/adb.13085 · Cited by 26
“In addition to these limitations, we did not predict that effects of gabapentin on brain metabolites would be specific to glutamate and not GABA.29–32 However, studies that reported an effect of chronic gabapentin dosing on increasing brain GABA levels have generally evaluated a higher dose of gabapentin (≥1800 vs. 12…”
BackgroundAlhaddad, H., Wong, W., Abou-Gharbia, M. A., Childers, W. E., Melenski, E., Bell, R. L., & Sari, Y. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001147 · Cited by 22
Rothwell, P. E., Kourrich, S., & Thomas, M. J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.038 · Cited by 23
“…in this neural circuit e which includes the nucleus accumbens (NAc) and ventral tegmental area (VTA) e develop over the course of chronic drug exposure and have been associated with drug craving and persistent vulnerability to relapse (Kalivas, 2009; Robinson and Berridge, 2003; Vezina, 2004).”
BackgroundImplication of NMDA receptors in behavioural sensitization to psychostimulants: A short review
Landa, L., Máchalová, A., & Šulcová, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.028 · Cited by 26
“…receptor system) is involved in the processes of behavioural sensitization elicited by many drugs of abuse (Cador et al., 1999; Fujio et al., 2005; Kalivas, 2009, 2004; Lee et al., 2011; Miyazaki et al., 2013; Ohmori et al., 1996, 1994; Shirai et al., 1996; Stewart and Druhan, 1993; Subramaniam…”
BackgroundMurnane, K. S., Gopinath, K., Maltbie, E. A., Daunais, J. B., Telesford, Q. K., & Howell, L. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3709-9 · Cited by 22
“Contemporary studies have related specific areas within the PFC to outcome valuation, behavioral inhibition, drug craving, and risky decisionmaking (Everitt and Robbins 2005; Garavan et al. 2000; George and Koob 2010; Jentsch and Taylor 1999; Kalivas 2009; Maas et al. 1998; Volkow et al. 2011).”
BackgroundPerrine, S., O'Leary-Moore, S. K., Galloway, M., Hannigan, J., & Bowen, S. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.001 · Cited by 20
“Functionally, a decrease in GLU or an increase in GABA is consistent with a shift away from neuronal excitation toward inhibition, and is also consistent with deficits in excitatory neurotransmission observed in rats after repeated exposure to a variety of addictive drugs (Kalivas, 2009).”
ResultNicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice
Storey, G. P., Gonzalez-Fernandez, G., Bamford, I. J., Hur, M., McKinley, J. W., Heimbigner, L., Minasyan, A., Walwyn, W. M., & Bamford, N. S. (2016) · eNeuro · doi:10.1523/eneuro.0095-15.2015 · Cited by 24
Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior
Mallick, F., & McCullumsmith, C. B. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0680-7 · Cited by 22
Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders
Slifstein, M., & Abi‐Dargham, A. (2016) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.09.002 · Cited by 25
Jones, J. A., Zühlsdorff, K., & Dalley, J. W. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15380 · Cited by 23
“The transition to addiction is hypothesised to involve a dysregulation of glutamate homeostasis and long- term changes in synaptic plasticity (van Huijstee & Mansvelder, 2015; Kalivas, 2009).”
He, Z., Chen, Y., Dong, H., Su, R., Gong, Z., & Yan, L. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.02.047 · Cited by 22
Duncan, J. R. (2012) · ISRN Neurology · doi:10.5402/2012/972607 · Cited by 26
“During extinction training drug-seeking actions do not yield a drug reward, removing the adaptive value of drug seeking (comparable to cue exposure therapy during rehabilitation in humans) (see [117]).”
BackgroundJia, W., Zhang, R., Wu, B., Dai, Z., Zhu, Y., Li, P., & Zhu, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087247 · Cited by 24
“A potential mechanism for addiction development that is supported by increasing evidence is the drug-induced enduring imbalance between synaptic and nonsynaptic glutamate in NAc, termed glutamate homeostasis [7].”
BackgroundPendyam, S., Mohan, A., Kalivas, P. W., & Nair, S. S. (2012) · Synapse · doi:10.1002/syn.21547 · Cited by 22
Self-citationCeglia, I., Lee, K.-W., Cahill, M. E., Graves, S. M., Dietz, D., Surmeier, D. J., Nestler, E. J., Nairn, A. C., Greengard, P., & Kim, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621185114 · Cited by 21
“NAc, including increasing dendritic spine density (9, 10, 16, 17).”
BackgroundAntal, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052356 · Cited by 27
“…their distant localization from the synaptic cleft, mGluR 2/3 receptors cannot be activated by glutamate released by the axon terminals of nociceptive primary afferents; thus, they may bind the glutamate released by adjacent astrocytes [50] and can influence synaptic transmission only indirectly.”
Astrocyte-Synapse Structural Plasticity in Neurodegenerative and Neuropsychiatric Diseases
Badia‐Soteras, A., Mak, A., Blok, T. M., Boers-Escuder, C., van den Oever, M. C., Min, R., Smit, A. B., & Verheijen, M. H. G. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.04.011 · Cited by 22
Gao, J., Jordan, C. J., Bi, G., He, Y., Yang, H.-J., Gardner, E. L., & Xi, Z. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0231-5 · Cited by 21
Oesterle, T., Karpyak, V. M., Coombes, B. J., Athreya, A. P., Breitinger, S. A., da Costa, S. C., & Gerberi, D. (2022) · American Journal on Addictions · doi:10.1111/ajad.13341 · Cited by 24
Woodward, J. J., & Braunscheidel, K. M. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100059 · Cited by 21
mGlu5 Receptor Functional Interactions and Addiction
Brown, R. M., Mustafa, S., Ayoub, M. A., Dodd, P. R., Pfleger, K. D. G., & Lawrence, A. J. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00084 · Cited by 24
“…the established involvement of plasticity in glutamatergic corticostriatal neurons in the reinstatement of drug-seeking in animal models of relapse (Kalivas, 2009), one may hypothesize that interactions between mGlu5 and A2AR have the potential to regulate drug-seeking or the conditioned effects…”
BackgroundMcGinty, J. F., Zelek-Molik, A., & Sun, W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.050 · Cited by 21
“Cocaine-induced deficits in the structure and/or function of the PFC have been demonstrated after both short and long access preclinical models (Briand et al., 2008; George et al., 2008; Kalivas 2009; Whitfield et al., 2011; Sun et al., 2013).”
BackgroundYates, J. R., Breitenstein, K. A., Gunkel, B. T., Hughes, M. N., Johnson, A. B., Rogers, K. K., & Shape, S. M. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.09.004 · Cited by 21
“…glutamatergic system has been linked to several disorders, including ADHD (see Archer and Garcia, 2016 for a review), OCD (see Grados et al., 2015 for a review), drug addiction (see Kalivas, 2009 for a review), psychopathy (Bortolato et al., 2012), and PG (see Pettorruso et al., 2014 for a review).”
Ieong, H. F.-H., Gao, F. Q., & Yuan, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-54316-6 · Cited by 22
“This may suggest that life-time opiate addiction, in addition to the existing clinical definition, is also a cerebrovascular disorder 1–3 that is linked to disturbed glutamate homeostasis 5 .”
Metabotropic glutamate receptor 5 in bulimia nervosa
Mihov, Y., Treyer, V., Akkus, F., Toman, E., Milos, G. F., Ametamey, S. M., Johayem, A., & Hasler, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-63389-7 · Cited by 22
Qu, L., Wang, Y., Li, Y., Wang, X., Li, N., Ge, S., Wang, J., Wang, G., Volkow, N. D., Lang, B., et al. (2020) · Theranostics · doi:10.7150/thno.44893 · Cited by 23
“In rodents, the prelimbic (PrL) and infralimbic (IL) regions of the mPFC modulate opioid related drug reward, dependence and withdrawal [19-21].”
BackgroundFaccidomo, S., Cogan, E. S., Hon, O. J., Hoffman, J. L., Saunders, B. L., Eastman, V. R., Kim, M. J., Taylor, S. M., McElligott, Z. A., & Hodge, C. W. (2021) · Addiction Biology · doi:10.1111/adb.13049 · Cited by 21
Molecular Diffusion Model of Neurotransmitter Homeostasis Around Synapses Supporting Gradients
Mohan, A., Pendyam, S., Kalivas, P. W., & Nair, S. S. (2011) · Neural Computation · doi:10.1162/neco_a_00101 · Cited by 23
“prefrontal cortex and the nucleus accumbens (Kalivas, 2009).”
Self-citationJordan, C. J., & Xi, Z.-X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.811192 · Cited by 20
“In addition to dopamine, the glutamate system plays a fundamental role in substance misuse and addiction (Kalivas, 2009).”
BackgroundInsights into the Neurobiology of Craving in Opioid Use Disorder
Lueptow, L. M., Shashkova, E., Miller, M. G., Evans, C. J., & Cahill, C. M. (2020) · Current anesthesiology reports · doi:10.1007/s40140-020-00420-7 · Cited by 21
Avalos, M. P., Guzman, A. S., Rigoni, D., Gorostiza, E. A., Sanchez, M. A., Mongi‐Bragato, B., García‐Keller, C., Perassi, E. M., Virgolini, M. B., Ramos, J. M. P., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.014 · Cited by 20
Addiction-induced plasticity in underlying neural circuits
Kourosh‐Arami, M., Komaki, A., & Gholami, M. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05778-y · Cited by 22
Inbar, K., Levi, L. A., & Kupchik, Y. M. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01285-6 · Cited by 22
Barlattani, T., Celenza, G., Cavatassi, A., Minutillo, F., Socci, V., Pinci, C., Santini, R., & Pacitti, F. (2024) · Current Neuropharmacology · doi:10.2174/011570159x343115241030094848 · Cited by 23
“Astrocytes also regulate neuronal glutamate release using the xc- sys-tem, which facilitates the uptake of extracellular cysteine while releasing intracellular glutamate at a 1:1 ratio [69-71].”
Sun, W. (2011) · Current Drug Abuse Reviews · doi:10.2174/1874473711104040270 · Cited by 23
“[2] Kalivas PW.”
BackgroundYates, J. R., Gunkel, B. T., Rogers, K. K., Hughes, M. N., & Prior, N. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4469-5 · Cited by 20
“…et al. 2012; Griffin et al. 2014; Jensen et al. 2009; Miller et al. 2014; Perlov et al. 2007; see Archer and Garcia 2016; Chang et al. 2014; Kalivas 2009; Lesch et al. 2013; Niciu et al. 2014; Pattij and Vanderschuren 2008 for reviews), and recent evidence has identified glutamate…”
BackgroundNeural systems mediating the inhibition of cocaine-seeking behaviors
Ewald, V. A. M., & LaLumiere, R. T. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.07.006 · Cited by 24
“…the NA are of particular importance for examining cocaine-associated memories, as evidence suggests that these differential projections allow dichotomous control over the NA and associated cocaine-seeking behavior (Gass and Chandler, 2013; Kalivas, 2009; Moorman et al., 2015; Peters et al., 2009).”
BackgroundTeal, L. B., Gould, R. W., Felts, A. S., & Jones, C. K. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.05.001 · Cited by 26
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date
Chalhoub, R., & Kalivas, P. W. (2020) · Drugs · doi:10.1007/s40265-020-01373-1 · Cited by 22
Self-citationWatts, J. J., Ramesh, R. G., Silva, T. M. S., Lalang, N., Chavez, S., & Mizrahi, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00764 · Cited by 20
“Along with observations of morphological and functional changes to anterior cingulate cortex (ACC) function (11–16), evidence suggests that dysregulation of glutamate metabolism in this brain region and neurotransmission plays a key role in the development and maintenance of substance use disorders (17).”
BackgroundLeyrer‐Jackson, J. M., Holter, M. C., Overby, P. F., Newbern, J. M., Scofield, M. D., Olive, M. F., & Gipson, C. D. (2020) · eNeuro · doi:10.1523/eneuro.0276-20.2020 · Cited by 20
“Further, drugs of abuse including nicotine induce changes in glutamatergic homeostasis within the mesocorticolimbic brain circuitry (Kalivas, 2009), thus altering glutamatergic-MSN connectivity and associated synaptic plasticity within the accumbens.”
BackgroundMcCutcheon, R. A., Pillinger, T., Rogdaki, M., Bustillo, J., & Howes, O. D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01455-y · Cited by 21
Kearns, A. M., Siemsen, B. M., Hopkins, J. L., Weber, R. A., Scofield, M. D., Peters, J., & Reichel, C. M. (2021) · Addiction Biology · doi:10.1111/adb.13097 · Cited by 20
“Normalization of glutamatergic signalling in this circuit alleviates drug seeking.(5,44) Thus, our findings support chemogenetic inhibition of the”
BackgroundTran, T. D. B., Nguyen, H. T., Sodergren, E. J., Dickson, P. E., Wright, S. N., Philip, V. M., Weinstock, G. M., Chesler, E. J., Zhou, Y., & Bubier, J. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109409 · Cited by 22
Weikop, P., Jensen, K. L., & Thomsen, M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0684-1 · Cited by 21
Oliveira, T. P. D., Gonçalves, B. D., Oliveira, B. S., de Oliveira, A. D., Reis, H., Ferreira, C. N., Aguiar, D., de Miranda, A. D., Ribeiro, F., Vieira, É., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.631311 · Cited by 17
“In addition, glutamatergic neurotransmission is an interesting target for binge-eating disorder treatment, as it plays a role in reinforcing action of natural stimuli, such as food and drug abuse (Bisaga et al., 2008; Gass and Olive, 2008; Kalivas, 2009; Guardia et al., 2011).”
BackgroundKroll, S. L., Hulka, L. M., Kexel, A.-K., Vonmoos, M., Preller, K. H., Treyer, V., Ametamey, S. M., Baumgartner, M. R., Boost, C., Pahlisch, F., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02628-7 · Cited by 19
“These fi ndings are consistent with both previous preclinical results recent human fi ndings reporting impaired glutamate homeostasis in the NAc in chronic CU [76, 77].”
ResultCastells‐Nobau, A., Puig, I., Motger‐Albertí, A., de la Vega-Correa, L., Rosell-Díaz, M., Arnoriaga‐Rodríguez, M., Escrichs, A., Garre‐Olmo, J., Puig, J., Ramos, R., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01157-x · Cited by 22
Leeman, R. F., Bogart, D., Fucito, L. M., & Boettiger, C. A. (2014) · Current Addiction Reports · doi:10.1007/s40429-013-0008-1 · Cited by 20
Rao, K. N., Sentir, A. M., Engleman, E. A., Bell, R. L., Hulvershorn, L. A., Breier, A. F., & Chambers, R. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4421-8 · Cited by 20
“1999; Goff and Coyle 2001; Jentsch and Roth 1999), addiction (Kalivas 2009; Rao et al. 2015), and their linkage (Chambers et al.”
Lebourgeois, S., Vilpoux, C., Jeanblanc, J., Acher, F., Marie, N., Noble, F., & Naassïla, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.031 · Cited by 19
“These neuroadaptations result in decreasing the mGlu2/3 tone, and, because mGlu2/3 have an inhibitory-release function, lead in turn to enhanced glutamate release (Kalivas, 2009).”
BackgroundYang, L., Guo, N., Fan, W., Ni, C., Huang, M., Bai, L., Zhang, L., Zhang, X., Wen, Y., Li, Y., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.03.006 · Cited by 19
The role of HINT1 protein in morphine addiction: An animal model‐based study
Liu, P., Chu, Z., Lei, G., Deng, L., Yang, L., & Dang, Y. (2020) · Addiction Biology · doi:10.1111/adb.12897 · Cited by 19
Nam, H. W., Lee, M. R., Hinton, D. J., & Choi, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.079 · Cited by 19
Constitutive Knockout of Kalirin-7 Leads to Increased Rates of Cocaine Self-Administration
Kiraly, D. D., Nemirovsky, N. E., LaRese, T. P., Tomek, S. E., Yahn, S. L., Olive, M. F., Eipper, B. A., & Mains, R. E. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087106 · Cited by 19
Scheller, K. J., Williams, S. J., Lawrence, A. J., & Djouma, E. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.004 · Cited by 20
“There is abundant literature on the mesocorticolimbic dopamine system and its role in mediating the reinforcing effects of ethanol and opioids (Everitt and Robbins, 2005; Kalivas, 2009; Koob and Volkow, 2010).”
BackgroundFischer, K. D., Houston, A. C. W., Desai, R. I., Doyle, M. R., Bergman, J., Mian, M. N., Mannix, R., Sulzer, D., Choi, S. J., Mosharov, E. V., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4848-1 · Cited by 19
“GLT-1 in particular, always assumed to be expressed in astrocytes, has been specifically implicated in phenomena related to withdrawal, specifically reinstatement (Kalivas 2009; Roberts-Wolfe and Kalivas 2015).”
Bosse, K. E., Charlton, J. L., Susick, L. L., Newman, B., Eagle, A. L., Mathews, T. A., Perrine, S. A., & Conti, A. C. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13235 · Cited by 18
Targeting neuroinflammation: The therapeutic potential of ω-3 PUFAs in substance abuse
Peng, S., Peng, Z., Qin, M., Huang, L., Zhao, B., Wei, L., Ning, J., Tuo, Q.-H., Yuan, T.-F., Shi, Z., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111058 · Cited by 18
Healey, K. L., Kibble, S., Bell, A., Hodges, S., & Swartzwelder, H. S. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24758 · Cited by 18
“The present report identifies several such potential mechanisms and may facilitate the development of therapeutic treatments. affected by other drugs of abuse (Kalivas, 2009; Kim et al., 2018).”
BackgroundGibuła‐Tarłowska, E., Wiszniewska, A., Turyk, M., Szymczyk, P., Kotlinska, J. H., & Kędzierska, E. (2025) · Molecules · doi:10.3390/molecules30132824 · Cited by 22
“Existing models suggest that ketamine’s blockade of NMDA receptors increases synap-togenesis by stimulating protein synthesis and the insertion of AMPA receptors [83,133,135].”
Zhou, S., Xue, L., Wang, X., Jiang, W., Xue, Y.-X., Liu, J., He, Y.-Y., Luo, Y., & Lü, L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2551-6 · Cited by 20
“However, other neurotransmitter systems within the brain, such as the glutamate system, are also critical for the centrally mediated effects of drugs (Harris and Aston-Jones 2003; Kalivas 2009; Kalivas et al. 2009; Wise 2008, 2009).”
Agmatine Prevents Adaptation of the Hippocampal Glutamate System in Chronic Morphine-Treated Rats
Wang, X.-F., Zhao, T.-Y., Su, R., Wu, N., & Li, J. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0031-z · Cited by 19
“Previous studies have indicated that naloxone-precipitated withdrawal and cueor drug-induced relapse lead to the enhancement of neuronal glutamate release in chronic opioid-treated animals, whereas the decrease in basal extracellular glutamate levels during chronic opioid treatment is due to reduced cystineglutamate e…”
BackgroundOne month of cocaine abstinence potentiates rapid dopamine signaling in the nucleus accumbens core
Cameron, C. M., Wightman, R. M., & Carelli, R. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.006 · Cited by 18
“Thus, a possible role of DA following abstinence may be modulation of glutamate signaling from the prefrontal cortex (PFC) to the NAc (Kalivas, 2009; Kalivas et al., 2005).”
BackgroundTargeting the GABAB Receptor for the Treatment of Substance Use Disorder
Frankowska, M., Przegaliński, E., & Filip, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-46044-4_14 · Cited by 19
Sadat‐Shirazi, M., Vousooghi, N., Alizadeh, B., Makki, S. S. M., Zarei, S. Z., Nazari, S., & Zarrindast, M. (2018) · Journal of Behavioral Addictions · doi:10.1556/2006.7.2018.35 · Cited by 18
“In addition to dopaminergic neurons, nucleus accumbens also receives glutamatergic information from regions, such as the thalamus, hippocampus, amygdala, and frontal cortex, which makes glutamate to interact with dopamine in the modulation of reward and reinforcement and development of addictive behaviors (Kalivas, 20…”
BackgroundInfluentialTraumatic brain injury and methamphetamine: A double-hit neurological insult
Hayek, S. E., Allouch, F., Razafsha, M., Talih, F. R., Gold, M. S., Wang, K., & Kobeissy, F. H. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116711 · Cited by 19
Kennedy, W. K., Leloux, M. R., Kutscher, E. C., Price, P. L., Morstad, A. E., & Carnahan, R. M. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425251003641975 · Cited by 22
Kuhn, B. N., Cannella, N., Crow, A. D., Roberts, A. T., Lunerti, V., Allen, C., Nall, R. W., Hardiman, G., Woods, L. C. S., Chung, D., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06235-0 · Cited by 18
“Non-dopaminergic processes also likely contribute toward phenotypic differences, such as differences in glutamatergic transmission (Kalivas 2009) and NAc tetrapartite synapse adaptations (for review see Kruyer et al.”
BackgroundSelf-citationArndt, D. L., Johns, K. C., Dietz, Z. K., & Cain, M. E. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4031-x · Cited by 19
“This group I metabotropic receptor contributes to the maintenance of glutamate homeostasis (Kalivas 2009) via regulation of the cystine-glutamate exchanger (Kupchik et al. 2012).”
InfluentialSuto, N., Elmer, G. I., Wang, B., You, Z., & Wise, R. A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0503-13.2013 · Cited by 21
“…data support the hypothesis that glutamate inputs to NAS core—along with glutamate inputs to other brain regions, such as VTA (Wise, 2009)— carry information regarding impending cocaine availability, and therefore is a potential source of cue-induced cocaine craving and relapse (Kalivas, 2009).”
Metadata
- Authors
- Kalivas, P. W.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Kalivas, Peter W.
- ORCID
- Kalivas, Peter W.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-01
- Volume
- 10
- Issue
- 8
- Pages
- 561-572
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2021594631
- Semantic Scholar
- 926519bbbfc2dba348202b61755ab1bafbd520ae
- Cited by
- 1,350
- References
- 151
- Citations by year
- 2026: 42 · 2025: 70 · 2024: 66 · 2023: 61 · 2022: 89 · 2021: 81 · 2020: 107 · 2019: 96 · 2018: 71 · 2017: 77 · 2016: 93 · 2015: 81 · 2014: 73 · 2013: 97 · 2012: 84
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 015, DA 003, DA 012)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- glutamate homeostasis, addiction, prefrontal cortex, nucleus accumbens, corticostriatal circuits, dendritic spine morphology, synaptic plasticity, neuroplasticity, drug-seeking behavior
- MeSH terms
- Animals, Homeostasis, Humans, Models, Biological, Nerve Net, Neural Pathways, Nucleus Accumbens, Prefrontal Cortex, Glutamic Acid, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.